156 related articles for article (PubMed ID: 14707275)
1. Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents.
Liu Y; Cheung LH; Hittelman WN; Rosenblum MG
Mol Cancer Ther; 2003 Dec; 2(12):1341-50. PubMed ID: 14707275
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: directed apoptotic events in vascular endothelial cells.
Liu Y; Cheung LH; Thorpe P; Rosenblum MG
Mol Cancer Ther; 2003 Oct; 2(10):949-59. PubMed ID: 14578460
[TBL] [Abstract][Full Text] [Related]
3. Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.
Liu Y; Zhang W; Niu T; Cheung LH; Munshi A; Meyn RE; Rosenblum MG
Neoplasia; 2006 Feb; 8(2):125-35. PubMed ID: 16611405
[TBL] [Abstract][Full Text] [Related]
4. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
Dälken B; Giesübel U; Knauer SK; Wels WS
Cell Death Differ; 2006 Apr; 13(4):576-85. PubMed ID: 16179940
[TBL] [Abstract][Full Text] [Related]
5. Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.
Cheung LH; Zhao Y; Alvarez-Cienfuegos A; Mohamedali KA; Cao YJ; Hittelman WN; Rosenblum MG
J Exp Clin Cancer Res; 2019 Jul; 38(1):332. PubMed ID: 31362764
[TBL] [Abstract][Full Text] [Related]
6. Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel.
Selbo PK; Rosenblum MG; Cheung LH; Zhang W; Berg K
PLoS One; 2009 Aug; 4(8):e6691. PubMed ID: 19690617
[TBL] [Abstract][Full Text] [Related]
7. Recombinant single-chain antibody fusion construct targeting human melanoma cells and containing tumor necrosis factor.
Liu Y; Cheung LH; Marks JW; Rosenblum MG
Int J Cancer; 2004 Feb; 108(4):549-57. PubMed ID: 14696119
[TBL] [Abstract][Full Text] [Related]
8. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin.
Rosenblum MG; Cheung LH; Liu Y; Marks JW
Cancer Res; 2003 Jul; 63(14):3995-4002. PubMed ID: 12873997
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic death concurrent with CD3 stimulation in primary human CD8+ T lymphocytes: a role for endogenous granzyme B.
Laforge M; Bidère N; Carmona S; Devocelle A; Charpentier B; Senik A
J Immunol; 2006 Apr; 176(7):3966-77. PubMed ID: 16547231
[TBL] [Abstract][Full Text] [Related]
10. Perforin-dependent nuclear entry of granzyme B precedes apoptosis, and is not a consequence of nuclear membrane dysfunction.
Trapani JA; Jans P; Smyth MJ; Froelich CJ; Williams EA; Sutton VR; Jans DA
Cell Death Differ; 1998 Jun; 5(6):488-96. PubMed ID: 10200500
[TBL] [Abstract][Full Text] [Related]
11. Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin.
Kanatani I; Lin X; Yuan X; Manorek G; Shang X; Cheung LH; Rosenblum MG; Howell SB
Cancer Chemother Pharmacol; 2011 Oct; 68(4):979-90. PubMed ID: 21327682
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B.
Alvarez de Cienfuegos A; Cheung LH; Mohamedali KA; Whitsett TG; Winkles JA; Hittelman WN; Rosenblum MG
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958685
[TBL] [Abstract][Full Text] [Related]
13. Surface charge-modification prevents sequestration and enhances tumor-cell specificity of a recombinant granzyme B-TGFα fusion protein.
Jabulowsky RA; Oberoi P; Bähr-Mahmud H; Dälken B; Wels WS
Bioconjug Chem; 2012 Aug; 23(8):1567-76. PubMed ID: 22759275
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induced by granzyme B-glycosaminoglycan complexes: implications for granule-mediated apoptosis in vivo.
Galvin JP; Spaeny-Dekking LH; Wang B; Seth P; Hack CE; Froelich CJ
J Immunol; 1999 May; 162(9):5345-50. PubMed ID: 10228010
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis.
Medema JP; Toes RE; Scaffidi C; Zheng TS; Flavell RA; Melief CJ; Peter ME; Offringa R; Krammer PH
Eur J Immunol; 1997 Dec; 27(12):3492-8. PubMed ID: 9464839
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu.
Cao Y; Mohamedali KA; Marks JW; Cheung LH; Hittelman WN; Rosenblum MG
Mol Cancer Ther; 2013 Jun; 12(6):979-91. PubMed ID: 23493312
[TBL] [Abstract][Full Text] [Related]
17. The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.
Liu Y; Zhang W; Cheung LH; Niu T; Wu Q; Li C; Van Pelt CS; Rosenblum MG
Neoplasia; 2006 May; 8(5):384-93. PubMed ID: 16790087
[TBL] [Abstract][Full Text] [Related]
18. Granzyme B encoded by the commonly occurring human RAH allele retains pro-apoptotic activity.
Sun J; Bird CH; Thia KY; Matthews AY; Trapani JA; Bird PI
J Biol Chem; 2004 Apr; 279(17):16907-11. PubMed ID: 14752093
[TBL] [Abstract][Full Text] [Related]
19. Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.
Zhou H; Mohamedali KA; Gonzalez-Angulo AM; Cao Y; Migliorini M; Cheung LH; LoBello J; Lei X; Qi Y; Hittelman WN; Winkles JA; Tran NL; Rosenblum MG
Mol Cancer Ther; 2014 Nov; 13(11):2688-705. PubMed ID: 25239934
[TBL] [Abstract][Full Text] [Related]
20. EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.
Oberoi P; Jabulowsky RA; Bähr-Mahmud H; Wels WS
PLoS One; 2013; 8(4):e61267. PubMed ID: 23573299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
